CING
USDCingulate Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$4.360
Kõrge
$4.730
Madal
$4.360
Maht
0.19M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
20.1M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.15M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Life365 Appoints Healthcare Veteran Jay Roberts as Chief Development Officer
Life365, a leading data engagement and virtual care company, today announced the appointment of healthcare executive and investor Jay Roberts as...
Ascendiant Capital Maintains Buy on Cingulate, Raises Price Target to $61
Ascendiant Capital analyst Edward Woo maintains Cingulate with a Buy and raises the price target from $60 to $61.
Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $11
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate with a Buy and lowers the price target from $12 to $11.
Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May
Seotud aktsiad
PCB
PCB Bancorp
XOMAP
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
UTMD
Utah Medical Products Inc.
EPD
Enterprise Products Partners L.P.
AMG
Affiliated Managers Group Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.